Nanotechnology in the diagnosis and treatment of lung cancer

Pharmacology & Therapeutics
Alexander M Cryer, Andrew J Thorley

Abstract

Lung cancer is an umbrella term for a subset of heterogeneous diseases that are collectively responsible for the most cancer-related deaths worldwide. Despite the tremendous progress made in understanding lung tumour biology, advances in early diagnosis, multimodal therapy and deciphering molecular mechanisms of drug resistance, overall curative outcomes remain low, especially in metastatic disease. Nanotechnology, in particular nanoparticles (NPs), continue to progressively impact the way by which tumours are diagnosed and treated. The unique physicochemical properties of materials at the nanoscale grant access to a diverse molecular toolkit that can be manipulated for use in respiratory oncology. This realisation has resulted in several clinically approved NP formulations and many more in clinical trials. However, NPs are not a panacea and have yet to be utilised to maximal effect in lung cancer, and medicine in a wider context. This review serves to: describe the complexity of lung cancer, the current diagnostic and therapeutic environment, and highlight the recent advancements of nanotechnology based approaches in diagnosis and treatment of respiratory malignancies. Finally, a brief outlook on the future directions of nanom...Continue Reading

References

Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·R RameshJ A Roth
Dec 26, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Gianmauro NumicoMarco Merlano
Aug 29, 2002·Cancer Investigation·Keith M Skubitz
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Aug 2, 2005·Lancet·Bruce W S RobinsonRichard A Lake
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas SchluepMark E Davis
Apr 7, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Natasha B LeighlF A Shepherd
Jun 3, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M R GreenM J Hawkins
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Apr 13, 2007·Expert Review of Anticancer Therapy·Douglas Marchion, Pamela Münster
Jul 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Wei HePhilip S Low
Aug 28, 2007·International Journal of Nanomedicine·Stewart D ChipmanJack W Singer
Dec 8, 2007·Acta Biochimica Et Biophysica Sinica·Yangguang ShaoBaiqu Huang
Apr 15, 2008·Advanced Drug Delivery Reviews·Yasuhiro Matsumura
May 13, 2008·Nature Reviews. Cancer·Klaus Strebhardt, Axel Ullrich
Jul 4, 2008·The New England Journal of Medicine·Shyamala MaheswaranDaniel A Haber
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Sep 13, 2008·Journal of Cancer Research and Clinical Oncology·Shoshana J Weiner, Siyamek Neragi-Miandoab
Sep 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Martin LundqvistKenneth A Dawson
Sep 26, 2008·The New England Journal of Medicine·Roy S HerbstScott M Lippman
Oct 9, 2008·Advanced Drug Delivery Reviews·James D ByrneLisa Brannon-Peppas
Jan 14, 2009·Bioconjugate Chemistry·Neal K DevarajRalph Weissleder
Jan 31, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·James SymanowskiSunil Sharma
Feb 7, 2009·Nature Nanotechnology·Daniel A HellerMichael S Strano
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueUNKNOWN North East Japan Gefitinib Study Group
Apr 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fabian VandermeersLuc Willems
Jun 16, 2009·Nature Materials·Andre E NelMike Thompson
Jun 30, 2009·Nature Biotechnology·Jennifer A MacDiarmidHimanshu Brahmbhatt
Jul 17, 2009·Expert Opinion on Investigational Drugs·Teni Boulikas
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W T LimB Chowbay

❮ Previous
Next ❯

Citations

Oct 28, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Ying ZhangDannong He
Mar 3, 2020·Frontiers in Cell and Developmental Biology·Amanda H Wong, Thai Tran
Dec 11, 2020·Acta Biomaterialia·Mohammad Norouzi, Pierre Hardy
Dec 23, 2020·Photodiagnosis and Photodynamic Therapy·Rui LiuYuping Suo
Feb 8, 2020·Cancer Letters·Jianhai WangHuaiyong Chen
Oct 30, 2020·International Journal of Biological Macromolecules·Yu ZhengXiaofang Li
Jun 2, 2021·Journal of Hematology & Oncology·Zhe ChengYongheng Chen
Jun 18, 2021·Nano-micro Letters·Shruti Rawal, Mayur Patel
Aug 11, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lina DongJingjing Li
Aug 29, 2021·Pharmaceutics·Giovanna C N B LôboSônia N Báo
Sep 3, 2021·Advanced Drug Delivery Reviews·Alba García-FernándezRamón Martínez-Máñez
Nov 28, 2021·Pharmaceutics·Mohammad DoroudianSeamas C Donnelly
Jan 12, 2022·ACS Biomaterials Science & Engineering·Heng LiuHao Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.